TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:38
CONDUIT PHARMACEUTICALS INC. ( CDT )
0.06USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-98.81%
CDT
SPY
32.66%
CDT
0.00%
SPY
108.59%
CDT
0.00%
SPY
302.52%
CDT
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
2.41
2.60
8.23
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.18
0.00
-0.26
107.77
0.00
0.03
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-0.89
37.26
3.87
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
4.32
1647.26
-2830.19
0.00
Other Earnings and Cash Flow Stats:
CONDUIT PHARMACEUTICALS INC. ( CDT ) Net Income TTM ($MM) is -13.62
CONDUIT PHARMACEUTICALS INC. ( CDT ) Operating Income TTM ($MM) is -12.80
CONDUIT PHARMACEUTICALS INC. ( CDT ) Owners' Earnings Annual ($MM) is 0.00
CONDUIT PHARMACEUTICALS INC. ( CDT ) Current Price to Owners' Earnings ratio is 0.00
CONDUIT PHARMACEUTICALS INC. ( CDT ) EBITDA TTM ($MM) is 68.79
CONDUIT PHARMACEUTICALS INC. ( CDT ) EBITDA Margin is 3.87%
Capital Allocation:
CONDUIT PHARMACEUTICALS INC. ( CDT ) has paid 0.00 dividends per share and bought back 24.715587 million shares in the past 12 months
CONDUIT PHARMACEUTICALS INC. ( CDT ) has reduced its debt by 5.262 million USD in the last 12 months
Capital Structure:
CONDUIT PHARMACEUTICALS INC. ( CDT ) Interest-bearing Debt ($MM) as of last quarter is 0
CONDUIT PHARMACEUTICALS INC. ( CDT ) Annual Working Capital Investments ($MM) are -273
CONDUIT PHARMACEUTICALS INC. ( CDT ) Book Value ($MM) as of last quarter is -10
CONDUIT PHARMACEUTICALS INC. ( CDT ) Debt/Capital as of last quarter is -3%
Other Balance Sheet Stats:
CONDUIT PHARMACEUTICALS INC. ( CDT ) has 0 million in cash on hand as of last quarter
CONDUIT PHARMACEUTICALS INC. ( CDT ) has 11 million of liabilities due within 12 months, and long term debt 0 as of last quarter
CONDUIT PHARMACEUTICALS INC. ( CDT ) has 41 common shares outstanding as of last quarter
CONDUIT PHARMACEUTICALS INC. ( CDT ) has 0 million USD of preferred stock value
Academic Scores:
CONDUIT PHARMACEUTICALS INC. ( CDT ) Altman Z-Score is 782.39 as of last quarter
CONDUIT PHARMACEUTICALS INC. ( CDT ) Piotroski Score is 7.00 as of last quarter
Corporate Governance:
CONDUIT PHARMACEUTICALS INC. ( CDT ) largest shareholder is owning shares at 0.00 ($MM) value
Dovet Ltd(an insider) Sold 939009 shares of CONDUIT PHARMACEUTICALS INC. ( CDT ) for the amount of $96530.13 on 2024-10-07
53.83% of CONDUIT PHARMACEUTICALS INC. ( CDT ) is held by insiders, and 3.00% is held by institutions
CONDUIT PHARMACEUTICALS INC. ( CDT ) went public on 2023-09-25
Other CONDUIT PHARMACEUTICALS INC. ( CDT ) financial metrics:
FCF:34.23
Unlevered Free Cash Flow:0.00
EPS:-0.62
Operating Margin:-0.89
Gross Profit Margin:37.26
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:283.44
Beta:0.00
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About CONDUIT PHARMACEUTICALS INC. ( CDT ) :
Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.